NCT01759576: A Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Volunteers With Varying Degrees of Kidney Function |
|
|
| Completed | 1 | 40 | US | Canagliflozin (JNJ-28431754), JNJ-28431754 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Renal Insufficiency, Healthy | 11/08 | 11/08 | | |
NCT01512849: A Study to Evaluate the PK/PD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment |
|
|
| Completed | 1 | 24 | Japan | TA-7284 Low, TA-7284 High | Mitsubishi Tanabe Pharma Corporation | Type 2 Diabetes Mellitus | 09/12 | 09/12 | | |
